Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1

被引:70
|
作者
Wishart, JM
Horowitz, M
Morris, HA
Jones, KL
Nauck, MA
机构
[1] Royal Adelaide Hosp, Dept Med, Adelaide, SA 5000, Australia
[2] Inst Med & Vet Sci, Div Clin Biochem, Adelaide, SA 5000, Australia
[3] Ruhr Univ Bochum, Dept Med, Knappschafts Krankenhaus, D-4630 Bochum, Germany
基金
英国医学研究理事会;
关键词
gastric emptying; glucagon-like peptide-1; glucose tolerance;
D O I
10.1016/S0196-9781(98)00052-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucagon-like peptide-1 (GLP-1) may play a role in regulating gastric emptying. The aim of this study was to determine the relationship between gastric emptying of glucose and plasma concentrations of GLP-1. Gastric emptying of 75 g of glucose dissolved in 350 ml of water was measured by the use of scintigraphy in 12 normal volunteers. Venous blood samples for measurement of GLP-1 were obtained immediately before and for 180 min after ingestion of glucose. Plasma GLP-1 rose rapidly from a baseline of 8.5 +/- 1.2 pmol/l to 14.3 +/- 1.3 pmol/l at 10 min (p = 0.024), with a peak of 19.2 +/- 3.0 pmol/l at 30 min (p = 0.0006) after the glucose drink. The rate of gastric emptying was inversely related to the early rise in GLP-1, e.g., the 50% emptying time was related to the change in GLP-1 from baseline at 10 min (r = 0.57; p < 0.05). We conclude that there is an inverse relationship between gastric emptying of glucose and plasma GLP-1. This observation is consistent with the concept that GLP-1 is a determinant of, rather than determined by, the rate of gastric emptying. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:1049 / 1053
页数:5
相关论文
共 50 条
  • [21] Glucagon-like peptide-1 (GLP-1) is a powerful inhibitor of gastric emptying of water in man
    NSslund, EB
    Bogefors, J
    GrybSck, P
    Jacobsson, H
    Holst, J
    Hellstrsm, PM
    GASTROENTEROLOGY, 1999, 116 (04) : A1052 - A1052
  • [22] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [23] Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus
    Cuthbertson, Joy
    Patterson, Steven
    O'Harte, Finbarr P.
    Bell, Patrick M.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (01): : 52 - 56
  • [24] Artificial Sweeteners Have No Effect on Gastric Emptying, Glucagon-Like Peptide-1, or Glycemia After Oral Glucose in Healthy Humans
    Wu, Tongzhi
    Bound, Michelle J.
    Standfield, Scott D.
    Bellon, Max
    Young, Richard L.
    Jones, Karen L.
    Horowitz, Michael
    Rayner, Christopher K.
    DIABETES CARE, 2013, 36 (12) : E202 - E203
  • [25] Glucagon-like peptide-1 and satiety
    S. R. Bloom
    Nature, 1997, 385 : 214 - 214
  • [26] Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists
    Jalleh, Ryan J.
    Jones, Karen L.
    Nauck, Michael
    Horowitz, Michael
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (11) : 1542 - 1543
  • [27] Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia
    Deane, Adam M.
    Nguyen, Nam Q.
    Stevens, Julie E.
    Fraser, Robert J. L.
    Holloway, Richard H.
    Besanko, Laura K.
    Burgstad, Carly
    Jones, Karen L.
    Chapman, Marianne J.
    Rayner, Chris K.
    Horowitz, Michael
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 215 - 221
  • [28] Pharmacological Actions of Glucagon-Like Peptide-1, Gastric Inhibitory Polypeptide, and Glucagon
    Sekar, R.
    Singh, K.
    Arokiaraj, A. W. R.
    Chow, B. K. C.
    INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 326, 2016, 326 : 279 - 341
  • [29] Glucagon-Like Peptide-1 and Diabetes
    Monami, Matteo
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [30] Glucagon-like peptide-1 and satiety
    G. van Dijk
    T. E. Thiele
    R. J. Seeley
    S. C. Woods
    I. L. Bernstein
    Nature, 1997, 385 : 214 - 214